Literature DB >> 7062075

Neurological involvement in hereditary transcobalamin II deficiency.

P K Thomas, A V Hoffbrand, I S Smith.   

Abstract

A case of hereditary transcobalamin II deficiency with neurological involvement is described. The patient presented in early infancy with megaloblastic anaemia and was treated with folinic acid from 6 weeks of age. The diagnosis of transcobalamin II deficiency was not made until he was 2 years old when he showed severely retarded intellectual development, ataxia and pyramidal deficit in the limbs. Following treatment with hydroxocobalamin, his condition has slowly improved but he has remained with a severe neurological deficit. The consequences of vitamin B12 deficiency on neurological development in infancy are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7062075      PMCID: PMC491269          DOI: 10.1136/jnnp.45.1.74

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  17 in total

1.  Hereditary transcobalamin II deficiency: clinical findings in a new family.

Authors:  W H Hitzig; U Dohmann; H J Pluss; D Vischer
Journal:  J Pediatr       Date:  1974-11       Impact factor: 4.406

2.  Neonatal megaloblastic anemia due to inherited transcobalamin II deficiency in two siblings.

Authors:  N Hakami; P E Neiman; G P Canellos; J Lazerson
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

3.  Animal model for subacute combined degeneration.

Authors:  J J Dinn; S McCann; P Wilson; B Reed; D Weir; J Scott
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

4.  Neurophysiological study of subacute combined degeneration.

Authors:  E J Fine; M Hallett
Journal:  J Neurol Sci       Date:  1980-03       Impact factor: 3.181

5.  Psychiatric aspects of pernicious anaemia: a prospective controlled investigation.

Authors:  R Shulman
Journal:  Br Med J       Date:  1967-07-29

6.  Abnormal propionic-methylmalonic-succinic acid metabolism in vitamin B12 deficiency and its possible relationship to the neurologic syndrome of pernicious anemia.

Authors:  R J Vivacqua; R M Myerson; D J Prescott; J L Rabinowitz
Journal:  Am J Med Sci       Date:  1966-05       Impact factor: 2.378

7.  Myeloneuropathy after prolonged exposure to nitrous oxide.

Authors:  R B Layzer
Journal:  Lancet       Date:  1978-12-09       Impact factor: 79.321

8.  Dihydrofolate reductase deficiency causing megaloblastic anemia in two families.

Authors:  G P Tauro; D M Danks; P B Rowe; M B Van der Weyden; M A Schwarz; V L Collins; B W Neal
Journal:  N Engl J Med       Date:  1976-02-26       Impact factor: 91.245

9.  Megaloblastic haemopoiesis in patients receiving nitrous oxide.

Authors:  J A Amess; J F Burman; G M Rees; D G Nancekievill; D L Mollin
Journal:  Lancet       Date:  1978-08-12       Impact factor: 79.321

10.  Inherited lack of transcobalamin II in serum and megaloblastic anaemia: a further patient.

Authors:  J F Burman; D L Mollin; N A Sourial; R A Sladden
Journal:  Br J Haematol       Date:  1979-09       Impact factor: 6.998

View more
  7 in total

Review 1.  Transcobalamin II deficiency: case report and review of the literature.

Authors:  Y Kaikov; L D Wadsworth; C A Hall; P C Rogers
Journal:  Eur J Pediatr       Date:  1991-10       Impact factor: 3.183

2.  Hereditary transcobalamin II deficiency: a 22 year follow up.

Authors:  P K Thomas; A V Hoffbrand
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

3.  Expression of transcobalamin II mRNA in human tissues and cultured fibroblasts from normal and transcobalamin II-deficient patients.

Authors:  N Li; S Seetharam; D S Rosenblatt; B Seetharam
Journal:  Biochem J       Date:  1994-07-15       Impact factor: 3.857

Review 4.  Genetic patterns of transcobalamin II and the relationships with congenital defects.

Authors:  M Fràter-Schröder
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

5.  Update on transcobalamin deficiency: clinical presentation, treatment and outcome.

Authors:  Y J Trakadis; A Alfares; O A Bodamer; M Buyukavci; J Christodoulou; P Connor; E Glamuzina; F Gonzalez-Fernandez; H Bibi; B Echenne; I Manoli; J Mitchell; M Nordwall; C Prasad; F Scaglia; M Schiff; B Schrewe; G Touati; M C Tchan; B Varet; C P Venditti; D Zafeiriou; C A Rupar; D S Rosenblatt; D Watkins; N Braverman
Journal:  J Inherit Metab Dis       Date:  2013-12-05       Impact factor: 4.982

Review 6.  Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications.

Authors:  Henrik Zetterberg
Journal:  Reprod Biol Endocrinol       Date:  2004-02-17       Impact factor: 5.211

7.  New insights into the metabolic and nutritional determinants of severe combined immunodeficiency.

Authors:  Martha S Field; Elena Kamynina; David Watkins; David S Rosenblatt; Patrick J Stover
Journal:  Rare Dis       Date:  2015-11-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.